MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202641084288 A) filed by Augment Therapeutics Private Limited on July 09, 2026, for Sn-38 Prodrugs With Built-In Nucleophile-Assisted Release Systems For Enzyme-Independent Activation.
Inventor includes Apparao Satyam.
The application for the patent was published on July 17, 2026, under issue no. 29/2026.
Abstract: Application no.:……………. ABSTRACT Title: SN-38 PRODRUGS WITH BUILT-IN NUCLEOPHILE-ASSISTED RELEASE SYSTEMS FOR ENZYME-INDEPENDENT ACTIVATION The present invention relates to SN-38 (D1) prodrugs incorporating Built-In Nucleophile-Assisted Release Systems (BINARS) linkers for enzyme-independent release of SN-38. Seventy-three compounds (A-1 t...